Metabolic Dependencies in Pancreatic Cancer

Por Vaziri-Gohar, Ali, Zarei, Mahsa, Brody, Jonathan R., Winter, Jordan M.
Publicado no Front Oncol (2018)

Corrigendum: Metabolic Dependencies in Pancreatic Cancer

Por Vaziri-Gohar, Ali, Zarei, Mahsa, Brody, Jonathan R., Winter, Jordan M.
Publicado no Front Oncol (2019)

Tendencies towards bottled drinking water consumption: Challenges ahead of polyethylene terephthalate (PET) waste management

Por Aslani, Hassan, Pashmtab, Parisa, Shaghaghi, Abdolreza, Mohammadpoorasl, Asghar, Taghipour, Hassan, Zarei, Mahsa
Publicado no Health Promot Perspect (2021)

Potent Inhibition of Breast Cancer by Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1) Antagonists

Por Hedrick, Erik, Li, Xi, Cheng, Yating, Lacey, Alexandra, Mohankumar, Kumaravel, Zarei, Mahsa, Safe, Stephen
Publicado no Breast Cancer Res Treat (2019)

A novel mouse model of hemangiopericytoma due to loss of Tsc2

Por Du, Heng, Dreier, John R, Zarei, Mahsa, Wu, Chin-Lee, Bronson, Roderick W, Kwiatkowski, David J
Publicado no Hum Mol Genet (2018)

Cavernous hemangioma of the liver: factors affecting disease progression in general hepatology practice

Por Etemadi, Arash, Golozar, Asieh, Ghassabian, Akhgar, Zarei, Mahsa, Taheri, Amir Pejman Hashemi, Dawsey, Sanford M., Malekzadeh, Reza
Publicado em 2011

Nuclear Receptor 4A2 (NR4A2) Is a Druggable Target for Glioblastomas

Por Karki, Keshav, Li, Xi, Jin, Un-Ho, Mohankumar, Kumaravel, Zarei, Mahsa, Michelhaugh, Sharon K., Mittal, Sandeep, Tjalkens, Ronald, Safe, Stephen
Publicado no J Neurooncol (2019)

RNA-binding Protein HuR Regulates Both Mutant and Wild-type IDH1 in IDH1-mutated Cancer

Por Zarei, Mahsa, Lal, Shruti, Vaziri-Gohar, Ali, O’Hayer, Kevin, Gunda, Venugopal, Singh, Pankaj K, Brody, Jonathan R, Winter, Jordan M
Publicado no Mol Cancer Res (2018)

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner

Por Lal, Shruti, Zarei, Mahsa, Chand, Saswati N., Dylgjeri, Emanuela, Mambelli-Lisboa, Nicole C., Pishvaian, Michael J., Yeo, Charles J., Winter, Jordan M., Brody, Jonathan R.
Publicado no Sci Rep (2016)

MITF is a driver oncogene and potential therapeutic target in kidney angiomyolipoma tumors through transcriptional regulation of CYR61

Por Zarei, Mahsa, Giannikou, Krinio, Du, Heng, Liu, Heng-Jia, Duarte, Melissa, Johnson, Sneha, Nassar, Amin H., Widlund, Hans R., Henske, Elizabeth P., Long, Henry W., Kwiatkowski, David J.
Publicado no Oncogene (2020)

Tumors with TSC mutations are sensitive to CDK7 inhibition through NRF2 and glutathione depletion

Por Zarei, Mahsa, Du, Heng, Nassar, Amin H., Yan, Rachel E., Giannikou, Krinio, Johnson, Sneha H., Lam, Hilaire C., Henske, Elizabeth P., Wang, Yubao, Zhang, Tinghu, Asara, John, Kwiatkowski, David J.
Publicado no J Exp Med (2019)

HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells

Por Romeo, Carmella, Weber, Matthew C., Zarei, Mahsa, DeCicco, Danielle, Chand, Saswati N., Lobo, Angie D., Winter, Jordan M., Sawicki, Janet A., Sachs, Jonathan N., Meisner-Kober, Nicole, Yeo, Charles J., Vadigepalli, Rajanikanth, Tykocinski, Mark L., Brody, Jonathan R.
Publicado no Mol Cancer Res (2016)

CRISPR Knockout of the HuR Gene Causes a Xenograft Lethal Phenotype

Por Lal, Shruti, Cheung, Edwin C., Zarei, Mahsa, Preet, Ranjan, Chand, Saswati N., Mambelli-Lisboa, Nicole C., Romeo, Carmella, Stout, Matthew C., Londin, Eric, Goetz, Austin, Lowder, Cinthya Y., Nevler, Avinoam, Yeo, Charles J., Campbell, Paul M., Winter, Jordan M., Dixon, Dan A., Brody, Jonathan R.
Publicado no Mol Cancer Res (2017)

Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer

Por Brody, Jonathan R., Yabar, Cinthya S., Zarei, Mahsa, Bender, Joseph, Matrisian, Lynn M., Rahib, Lola, Heartwell, Craig, Mason, Kimberly, Yeo, Charles J., Peiper, Stephen C., Jiang, Wei, Varieur, Katelyn, Madhavan, Subha, Petricoin, Emanuel, Fortuna, Danielle, Curtis, Mark, Wang, Zi-Xuan, Pishvaian, Michael J., Winter, Jordan M.
Publicado no Cancer Biol Ther (2018)

Post-transcriptional regulation of PARG mRNA by HuR facilitates DNA repair and resistance to PARP inhibitors

Por Chand, Saswati N., Zarei, Mahsa, Schiewer, Matthew J., Kamath, Akshay R., Romeo, Carmella, Lal, Shruti, Cozzitorto, Joseph A., Nevler, Avinoam, Scolaro, Laura, Londin, Eric, Jiang, Wei, Meisner-Kober, Nicole, Pishvaian, Michael J., Knudsen, Karen E., Yeo, Charles J., Pascal, John M., Winter, Jordan M., Brody, Jonathan R.
Publicado no Cancer Res (2017)

Posttranscriptional Upregulation of IDH1 by HuR Establishes a Powerful Survival Phenotype in Pancreatic Cancer Cells

Por Zarei, Mahsa, Lal, Shruti, Parker, Seth J., Nevler, Avinoam, Vaziri-Gohar, Ali, Dukleska, Katerina, Mambelli-Lisboa, Nicole C., Moffat, Cynthia, Blanco, Fernando F., Chand, Saswati N., Jimbo, Masaya, Cozzitorto, Joseph A., Jiang, Wei, Yeo, Charles J., Londin, Eric R., Seifert, Erin L., Metallo, Christian M., Brody, Jonathan R., Winter, Jordan M.
Publicado no Cancer Res (2017)